Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Molecular modeling-based inclusion mechanism and stability studies of doxycycline and hydroxypropyl-β-cyclodextrin complex for ophthalmic delivery.

Zhang H, Chen M, He Z, Wang Z, Zhang M, He Z, Wan Q, Liang D, Repka MA, Wu C.

AAPS PharmSciTech. 2013 Mar;14(1):10-8. doi: 10.1208/s12249-012-9877-1. Epub 2012 Nov 17.

2.

Alpinetin/hydroxypropyl-β-cyclodextrin host-guest system: preparation, characterization, inclusion mode, solubilization and stability.

Ma SX, Chen W, Yang XD, Zhang N, Wang SJ, Liu L, Yang LJ.

J Pharm Biomed Anal. 2012 Aug-Sep;67-68:193-200. doi: 10.1016/j.jpba.2012.04.038. Epub 2012 May 3.

PMID:
22633603
3.

Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.

Dollo G, Le Corre P, Chollet M, Chevanne F, Bertault M, Burgot JL, Le Verge R.

J Pharm Sci. 1999 Sep;88(9):889-95.

PMID:
10479350
4.

Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.

Ungaro F, Giovino C, Catanzano O, Miro A, Mele A, Quaglia F, La Rotonda MI.

Int J Pharm. 2011 Feb 14;404(1-2):49-56. doi: 10.1016/j.ijpharm.2010.10.050. Epub 2010 Nov 5.

PMID:
21056648
5.

Characterization of an inclusion complex of cholesterol and hydroxypropyl-beta-cyclodextrin.

Williams RO 3rd, Mahaguna V, Sriwongjanya M.

Eur J Pharm Biopharm. 1998 Nov;46(3):355-60.

PMID:
9885309
6.

Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.

Aleem O, Kuchekar B, Pore Y, Late S.

J Pharm Biomed Anal. 2008 Jul 15;47(3):535-40. doi: 10.1016/j.jpba.2008.02.006. Epub 2008 Feb 15. Review.

PMID:
18367363
8.

Insulin complexation with hydroxypropyl-beta-cyclodextrin: Spectroscopic evaluation of molecular inclusion and use of the complex in gel for healing of pressure ulcers.

Valentini SR, Nogueira AC, Fenelon VC, Sato F, Medina AN, Santana RG, Baesso ML, Matioli G.

Int J Pharm. 2015 Jul 25;490(1-2):229-39. doi: 10.1016/j.ijpharm.2015.05.037. Epub 2015 May 15.

PMID:
25987212
9.
10.

Inclusional complex study between 6-p-toluidinylnaphthalene-2-sulfonate and 2-hydroxypropyl-beta-cyclodextrin.

Dotsikas Y, Loukas YL.

J Biochem Biophys Methods. 2002 Jul 31;52(2):121-34.

PMID:
12204416
11.

Studies on 6-chloro-5-(1-naphthyloxy)-2-(trifluoromethyl)-1H-benzimidazole/2-hydroxypropyl-β-cyclodextrin association: Characterization, molecular modeling studies, and in vivo anthelminthic activity.

Rojas-Aguirre Y, Yépez-Mulia L, Castillo I, López-Vallejo F, Soria-Arteche O, Hernández-Campos A, Castillo R, Hernández-Luis F.

Bioorg Med Chem. 2011 Jan 15;19(2):789-97. doi: 10.1016/j.bmc.2010.12.015. Epub 2010 Dec 9.

PMID:
21190860
12.

PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).

Gupta V, Davis M, Hope-Weeks LJ, Ahsan F.

Pharm Res. 2011 Jul;28(7):1733-49. doi: 10.1007/s11095-011-0409-6. Epub 2011 Apr 6.

PMID:
21626061
13.

Hydroxypropyl methylcellulose microspheres with piroxicam and piroxicam-hydroxypropyl-beta-cyclodextrin inclusion complex.

Jug M, Bećirević-Laćan M, Cetina-Cizmek B, Horvat M.

Pharmazie. 2004 Sep;59(9):686-91.

PMID:
15497750
14.

Investigation of inclusion complex of epothilone A with cyclodextrins.

Xiao CF, Li K, Huang R, He GJ, Zhang JQ, Zhu L, Yang QY, Jiang KM, Jin Y, Lin J.

Carbohydr Polym. 2014 Feb 15;102:297-305. doi: 10.1016/j.carbpol.2013.11.049. Epub 2013 Dec 4.

PMID:
24507285
15.

Complex formation of chlorhexidine gluconate with hydroxypropyl-β-cyclodextrin (HPβCD) by proton nuclear magnetic resonance spectroscopy ((1)H NMR).

Onnainty R, Longhi MR, Granero GE.

Carbohydr Res. 2011 Jun 1;346(8):1037-46. doi: 10.1016/j.carres.2011.03.028. Epub 2011 Mar 23.

PMID:
21489411
16.

Triamcinolone solubilization by (2-hydroxypropyl)-β-cyclodextrin: A spectroscopic and computational approach.

Miro A, Ungaro F, Balzano F, Masi S, Musto P, La Manna P, Uccello-Barretta G, Quaglia F.

Carbohydr Polym. 2012 Oct 15;90(3):1288-98. doi: 10.1016/j.carbpol.2012.06.075. Epub 2012 Jul 1.

PMID:
22939343
17.

Sulfisoxazole/cyclodextrin inclusion complex incorporated in electrospun hydroxypropyl cellulose nanofibers as drug delivery system.

Aytac Z, Sen HS, Durgun E, Uyar T.

Colloids Surf B Biointerfaces. 2015 Apr 1;128:331-8. doi: 10.1016/j.colsurfb.2015.02.019. Epub 2015 Feb 17.

PMID:
25769282
18.

Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery.

Battu SK, Repka MA, Maddineni S, Chittiboyina AG, Avery MA, Majumdar S.

AAPS PharmSciTech. 2010 Sep;11(3):1466-75. doi: 10.1208/s12249-010-9520-y. Epub 2010 Sep 15.

19.

Encapsulation of gallic acid/cyclodextrin inclusion complex in electrospun polylactic acid nanofibers: Release behavior and antioxidant activity of gallic acid.

Aytac Z, Kusku SI, Durgun E, Uyar T.

Mater Sci Eng C Mater Biol Appl. 2016 Jun;63:231-9. doi: 10.1016/j.msec.2016.02.063. Epub 2016 Feb 26.

PMID:
27040215
20.

Supplemental Content

Support Center